🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 1 día
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 89,10 89,46 87,57 87,57 -2,19% 2,12% 1.875.398
01/02/2024 93,24 93,24 88,92 89,53 -4,10% 4,63% 2.363.988
31/01/2024 92,64 94,29 92,40 93,36 +0,98% 2,04% 2.044.391
30/01/2024 92,50 92,91 92,16 92,45 -0,24% 0,81% 1.171.199
29/01/2024 92,58 93,03 92,45 92,67 +0,64% 0,63% 1.065.962
26/01/2024 91,67 92,74 91,67 92,08 +0,44% 1,17% 1.429.576
25/01/2024 92,02 92,24 91,04 91,68 -0,94% 1,30% 1.515.921
24/01/2024 91,01 92,98 90,80 92,55 -0,01% 2,40% 1.473.204
23/01/2024 93,62 93,95 91,86 92,56 -1,74% 2,23% 1.781.875
22/01/2024 93,71 94,59 93,57 94,20 +0,17% 1,09% 1.164.771
19/01/2024 94,94 95,45 93,74 94,04 -0,69% 1,80% 1.149.478
18/01/2024 93,95 94,73 92,45 94,69 -0,72% 2,43% 1.588.776
17/01/2024 94,18 95,59 94,04 95,38 +0,18% 1,65% 1.356.814
16/01/2024 94,74 95,49 94,08 95,21 +0,90% 1,49% 1.051.486
15/01/2024 94,93 95,20 94,20 94,36 -1,35% 1,05% 965.318
12/01/2024 95,70 96,50 95,34 95,65 +0,58% 1,21% 1.059.891
11/01/2024 95,32 95,85 94,86 95,10 +0,26% 1,04% 1.275.009
10/01/2024 94,26 95,30 94,11 94,85 -0,36% 1,26% 1.385.898
09/01/2024 94,43 95,39 94,31 95,19 +1,13% 1,14% 1.119.138
08/01/2024 93,43 94,29 93,38 94,13 +0,70% 0,97% 910.391
05/01/2024 93,27 93,95 92,44 93,48 +0,70% 1,62% 1.311.683
04/01/2024 92,52 93,19 92,25 92,83 +0,92% 1,02% 1.152.280
03/01/2024 91,86 92,49 91,37 91,98 +1,20% 1,22% 1.178.887
02/01/2024 90,06 91,08 89,88 90,89 +1,26% 1,33% 1.097.645
29/12/2023 89,30 89,89 89,24 89,76 +0,56% 0,73% 852.439
28/12/2023 89,64 89,89 89,19 89,26 +0,10% 0,78% 757.652
27/12/2023 88,61 89,54 88,41 89,17 -0,19% 1,28% 957.760
22/12/2023 89,12 89,58 88,96 89,34 +0,43% 0,70% 1.082.587
21/12/2023 87,73 89,03 87,62 88,96 -0,24% 1,61% 953.509
20/12/2023 89,11 89,38 88,62 89,17 +0,27% 0,85% 1.324.596